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A neglected area of cardiovascular research-study of the
mechanisms of acute disease onset-is receiving increased atten-
tion. The new interest is based on the undisputed findings that
onset of myocardial infarction and sudden cardiac death are mare
likely soon after awakening, indicating that activities of the patient
frequently trigger the diseases. Triggering may occur when
stressors produce hemodynamic, vlasoconstrictive and prothrom-
An important new direction of cardiovascular research--an
attempt to identify the mechanisms of acute disease on-
set-is now emerging. The effort is based in part on the
recognition that activities of the patient frequently play a
prominent role in triggering the onset of acute cardiovascular
disease (1) . The acute precipitant may act by causing disrup-
tion of a vulnerable coronary artery plaque and occlusive
thrombus formation producing acute myocardial infarction
and sudden cardiac death . This relatively simple, yet new,
insight into a mechanism of disease onset suggests research
approaches that may lead to methods for preventing the
leading cause of death in the industrialized world .
The relative position of this new field of research on acute
risk factors is shown in Figure 1 . The narrow column in the
center of the figure indicates the onset of coronary throm-
bosis causing nonfatal myocardial infarction or sudden car-
diac death . The four wide columns represent research areas
focusing on the different stages of coronary artery disease .
Chronic risk factors, acute treatment and long-term manage-
ment have been areas of intense research interest and
considerable progress . In contrast, the events that occur in
the hours and minutes before the onset of thrombosis and are
the causes of conversion of chronic to acute disease-have
received relatively little attention .
Scientific background for the new field . The increased
prospects for success in this hitherto difficult and relatively
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bode force cease risk factors-that,
in the presence of a vulner-
able atherosclerotic plaque, cause plaque disruption and throm .
bosis. Triggering research may clarify mechanisms and suggest
measures to sever the linkage between a potential trigger and its
pathologic consequence .
(J Ain Coll Cardiol 1994,23 :809-13)
unapproachable field of study result from the multiple ad-
vances in understanding of acute coronary artery disease
achieved during the 1980s . The work of DeWood et al . (2)
clearly established that acute thrombosis causes myocardial
infarction . Davies and Thomas (3), Falk (4) and others,
building on the pioneering studies of Constantinides in the
1960s (5), identified the pathoanatomic role of plaque disrup-
tion and thrombosis in sudden death and unstable angina, as
well as in myocardial infarction . Fuster and colleagues (6)
characterized the types of arterial injury likely to produce
thrombosis, and VVillenon et al . (7) identified interventions
capab!e of modifying conversion of chronic to acute disease
in experimental animals . Randomized clinical trials have
demonstrated that aspirin (8), beta-adrenergic blocking
agents (9), lipid-lowering regimens (10) and, more recently,
angiotensin-converting enzyme inhibitors (11) can prevent
myocardial infarction, but the mechanisms of the beneficial
effects are not fully identified .
Our group (12,13) provided the first objective evidence
that infarction onset is more frequent in the hours after
awakening, thus identifying triggering of onset by activities
of the patient . Plaques that are disrupted and cause disease
onset have been found to contain higher concentrations of
lipids and macrophages than are found in nondisrupted
plaques (14,15). Finally, it is now recognized that the entire
sequence of plaque disruption and occlusive thrombosis
often begins in lesior,.s previously causing <50% reduction of
the diameter of the arterial lumen, as judged by prior
angiograms (16) and angiographic assessment, after throm-
bolysis .
Although these gains in understanding are impressive, the
field of triggering remains relatively unexplored, and only a
small fraction of its potential benefit has yet been realized .
Heart attack, the term for the combined disorders of myo-
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cardial infarction and sudden cardiac death, continues to
account for an estimated 500,000 deathslycar in the United
States (18) . Even the optimal utilization of thrombolytic
therapy for myocardial infarction-the advance on which the
greatest attention has been focused-could prevent only
25,000 deaths acutely, or 5% of the total, because most
deaths occur suddenly before any type of treatment can be
initiated (19) . A major challenge for the 1990s is to use the
advances of the 1980s as starting points to identify, and
subsequently block, the acute processes triggering onset of
coronary artery disease .
Triggers, acute risk factors and vulnerable plaques. Three
important concepts-triggers, acute risk factors and vulner-
able plaques--provide an intellectual frameword for under-
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Figure 1 . Position of the relatively undeveloped area of
research on conversion of chronic to acute disease with
respect to the traditional areas of research on coronary
artery disease. ASA = aspirin; CABG = coronary
artery bypass grafting ; EP = electrophysiologic ; Efl' =
exercise treadmill testing ; MI = myocardial infarction ;
P'I'CA = coronary angioplasty .
standing disease onset . Definitions and the relation among
the three concepts are presented in Figure 2 .
Figure 3 presents an expanded version of this concept,
demonstrating its interaction with the established patho-
physiologic features of myocardial infarction and sudden
cardiac death .
The process begins with a nonvulnerable atherosclerotic
plaque shown on the left . This plaque may become vulner-
able to disruption, for reasons that are poorly understood at
present but include increases in macrophage and lipid con-
tent and inflammatory cell products . At this point, hemody-
namic or vasoconstrictive forces generated by a physical or
psychologic stress might disrupt the plaque . If the plaque
disruption produces a major thrombogenic stimulus such as
I
Figure 2 . Definitions and the relations among trig-
gers, acute risk factors and vulnerable plaques .
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a type III lesion with medial injury, an occlusive thrombus
forms rapidly leading to myocardial infarction or sudden
death. If the plaque disruption produces only a minor
thrombogenic stimulus, the patient may be asymptomatic,
yet platelet aggregates and thrombin generation may contrib-
ute to growth of the plaque or cause unstable angina or
non-Q-wave myocardial infarction (20) . At this point . other
external triggering activities could cause the artery to con-
strict and the thrombus to become occlusive or couldlead to
increased coagulability, causing the clot to grow, leading to
complete occlusion and myocardial infarction or sudden
death .
Disease onset due to triggered disruption of nonstenotic
lesions requires an addition to the traditional view of the
process through which an atherosclerotic plaque grows and
eventually produces clinical symptoms. The traditional
teaching has been that atherosclerotic plaques cause disease
after passing through the stages of the fatty streak and the
fibrous plaque to the stenotic, complicated lesion . The new
understanding warrants addition of a significant pathway to
clinical disease through disruption of a nonstenotic vulnera-
ble plaque .
Unquestionably, the best approach to prevention of cor-
onary artery disease is primary prevention of atherosclero-
sis, and extensive research tow2rd this goal must continue .
However, a multifaceted approach is warranted and pursuit
of the opportunities exposed by this new information is
essential. The efforts are complementary and there is a high
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Figure 3 . Illustration of a hypothetical method by which daily
activities may trigger coronary thrombosis . Three triggering mech-
ft
anisms are presented : 1) physical or mental stress producing hemo-
namic changes leading to plaque rupture, 2) activities causing an
increase in coagulability, and 3) stimuli leading to vasoconstriction .
The scheme depicting the role of coronary thrombosis in unstable
angina, myocardial infarction and sudden cardiac death has been
well described by numerous investigators . The novel portion of this
figure is the additional of triggers . See text and Muller et al . (1)
for detailed discussion . Non-Q-Ml = non-Q wave myocardial
infarction .
likelihood that the basic scientific methods developed for
study of the fatty streak can be used to identify the mecha-
nisms through which more advanced plaques become vul-
nerable to disruption .
It is possible to understand much of the success of
preventive therapy through interference with various acute
processes. For instance, aspirin can prevent infarction by
preventing increases in coagulability, whereas beta-blockade
could possibly reduce the hemodynamic stresses leading to
plaque disruption . The successful reduction of acute coro-
nary events by lipid-lowering therapy demonstrated by
Brown et al . (21) may well have been achieved by reducing
plaque vulnerability or coagulability, as indicated by the
finding that fewer nonstenotic plaques produced coronary
events in the groups with the more significant lipid lowering .
As in aty new field, there are many unanswered ques-
tions. What are the triggers of onset? For what percent of
812
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events can a trigger be identified? How do the triggers
operate? What are the acute risk factors produced by the
trigger? Is it possible to sever the link between a potential
trigger and its pathologic consequence? Can we prospec-
tively identify plaques vulnerable to disruption? Can such
vulnerable plaques be treated?
New researd opportunities .
Recent progress in scientific
methods on the epidemiologic, clinical and basic science
levels provides the opportunity to address these previously
unanswerable questions . On the epidemiologic level, a new
technique termed the "case-crossover" analysis has been
developed by Maclure and Mittleman (12,22,23) and suc-
cessfully utilized to analyze triggering of infarction by heavy
physical exertion. The method utilizes each patient as his or
her own control for the expected frequency of a potential
triggering activity in a 1-h hazard period before the onset of
the event. This permits comparison of observed to expected
frequencies without the confounding encountered in tradi-
tional case-control studies. Comparison of triggering in
various subgroups of patients can also suggest differences in
pathophysiology of onset, as demonstrated by the observa-
tion that patients with prior beta-adrenergic blockade do not
have the increase in infarction in the hours after awakening
observed in those now receiving such therapy (23) .
On the clinical level, the response to thrombolytic ther-
apy and the new technology of the catheterization laboratory
provide new opportunities to study this process . For in-
stance, with intracoronary angioscopy, it is now possible to
visualize in living patients the disrupted lesions causing the
acute coronary syndromes (24), rather than relying solely on
autopsy studies that are complicated by patient selection and
postmortem changes . Angioscopy, with its ability to detect
yellow plaques and red versus white thrombus, may aid in
the search for surface characteristics of the vulnerable
plaque. Intracoronary ultrasound (25), with its ability to
penetrate beneath the lumen surface and reveal certain
tissue characteristics, may have the potential to detect
within the arterial wall lipid-rich plaques that arc vulnerable
to disruption .
On the basic science level, developments in cellular and
molecular biology offer promise of methods to control acute
risk factors and treat vulnerable plaques . For instance, once
the mechanisms controlling chronic endogenous fibrinolytic
activity are sufficiently understood, it might be possible to
eliminate the daily decreases in endogenous fibrinolysis that
possibly contribute to the occurrence of coronary thrombo-
sis. If the growth factors (26) and chemotactic agents (27)
controlling macrophage infiltration of plaques were fully
identified, perhaps the development of vulnerable plaques
could be prevented. Fortunately, there is an animal model of
triggering developed more than 30 years ago by Dr . Paris
Constantinides and his colleagues (28) in which these ideas
can be explored
. The injection of Russell viper venom, a
-oteolytic procoagulant, into atherosclerotic rabbits trig-
gers localized platelet-rich throw i remarkably similar to
those observed in patients . Reintroduction of this model will
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permit study on the basic science level of many aspects of
the triggering process (29) .
Thus, a broad new area of potential research is now
apparent, and the tools with which to address its major
questions are available . Numerous signs indicate that the
area is receiving increased attention. Epidemiology, which
has in the past focused on chronic risk factors, has recently
devoted increased attention ro acute risk factors. Clinical
cardiology, which has directed its efforts toward treatment
of the disease once it has occurred, is now examining
findings during the acute onset of disease to reason back-
ward to the triggering events . Journals are featuring trigger-
ing Prticles, and both the American He Association and
the American College of Cardiology have created structured
sessions for presentation of triggering research . The greatest
impetus to the rapid development of this field would be an
increase in federal funding . Unfortunately, the limited Na-
tional Institutes of Health budget has severely curtailed the
active pursuit of this and other new scientific opportunities .
Although the rate of research progress may not be opti-
mal, the continued unacceptably high rates of morbidity and
mortality from heart attack, and the great potential that
could result from understanding triggering, ensure that ad-
vances in this field will continue . Conventional attempts to
reduce the annual 500, deaths from heart attacks must be
vigorously pursued, but the reduction of chronic risk factors
becomes progressively more difficult, and even as effective a
treatment as thrombolysis can prevent only a limited number
of heart attack deaths . Insight into triggering and acute risk
factors offers a new approach to prevention by identifying
and treating the plaques that are vulnerable to rt :pture, and
by finding means to sever the linkage betweer a potential
trigger and its catastrophic consequences . This rtew ap-
proach has great potential to continue and accelerate the
decline in cardiovascular disease .
We are grateful for the assistance of Kathleen Carney in the preparation of the
manuscript and to Paris Constantinides. MD for his pioneering work and
helpful consultation.
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